|
|
News Breaks
|
October 28, 2009
|
| 16:48 EDT |  | THRX |
| theflyonthewall.com: | Theravance and Astellas announce submission of Telavancin MAA to EMEA | | Theravance and Astellas Pharma announced that Astellas Europe submitted a Marketing Authorization Application, or MAA, to the European Medicines Agency, or EMEA, for telavancin, a bactericidal, once-daily injectable lipoglycopeptide antibiotic, for the treatment of nosocomial pneumonia, or NP, including ventilator-associated pneumonia, and complicated skin and soft tissue infections, or cSSTI, in adults. :theflyonthewall.com |
|
|
News For THRX From The Last 14 Days Check below for free stories on THRX the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2012
|
| 16:22 EDT |  | THRX |
|
|
January 31, 2012
|
| 11:21 EDT |  | THRX |
| | 10:28 EDT |  | THRX |
| | 06:11 EDT | | THRX |
| theflyonthewall.com: | Theravance initiated with an Underweight at Morgan Stanley | | Target $12. :theflyonthewall.com |
|
|
|
|
|
Subscribe for More Information